<DOC>
	<DOCNO>NCT00818272</DOCNO>
	<brief_summary>This observational study line German educational plan aim implement tool increase monitor awareness tuberculosis screen reinforce patient eligibility treatment Remicade accord Summary Product Characteristics ( SmPc ) .</brief_summary>
	<brief_title>Remicade Safety Line ( Crohn 's Disease ) ( Study P03288 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Subjects Crohn 's disease . As per SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>